DE20305898U1 - Pharmaceutical compositions include vitamins and optionally trace elements to enhance the therapeutic effect and/or reduce the side effects of drugs - Google Patents
Pharmaceutical compositions include vitamins and optionally trace elements to enhance the therapeutic effect and/or reduce the side effects of drugsInfo
- Publication number
- DE20305898U1 DE20305898U1 DE20305898U DE20305898U DE20305898U1 DE 20305898 U1 DE20305898 U1 DE 20305898U1 DE 20305898 U DE20305898 U DE 20305898U DE 20305898 U DE20305898 U DE 20305898U DE 20305898 U1 DE20305898 U1 DE 20305898U1
- Authority
- DE
- Germany
- Prior art keywords
- vitamin
- vitamins
- side effects
- reduce
- complex
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 229940088594 vitamin Drugs 0.000 title claims abstract description 41
- 229930003231 vitamin Natural products 0.000 title claims abstract description 41
- 235000013343 vitamin Nutrition 0.000 title claims abstract description 41
- 239000011782 vitamin Substances 0.000 title claims abstract description 41
- 230000001225 therapeutic effect Effects 0.000 title claims abstract description 14
- 239000011573 trace mineral Substances 0.000 title claims abstract description 9
- 235000013619 trace mineral Nutrition 0.000 title claims abstract description 9
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 title 1
- 230000000694 effects Effects 0.000 claims abstract description 14
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 46
- 239000011718 vitamin C Substances 0.000 claims description 25
- 235000019154 vitamin C Nutrition 0.000 claims description 25
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 23
- 229930003268 Vitamin C Natural products 0.000 claims description 23
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 claims description 19
- 235000019156 vitamin B Nutrition 0.000 claims description 19
- 239000011720 vitamin B Substances 0.000 claims description 19
- 229940046001 vitamin b complex Drugs 0.000 claims description 18
- MKUXAQIIEYXACX-UHFFFAOYSA-N aciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 claims description 15
- 229960004150 aciclovir Drugs 0.000 claims description 15
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 14
- 238000002360 preparation method Methods 0.000 claims description 13
- HOZOZZFCZRXYEK-GSWUYBTGSA-M butylscopolamine bromide Chemical compound [Br-].C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3[N+]([C@H](C2)[C@@H]2[C@H]3O2)(C)CCCC)=CC=CC=C1 HOZOZZFCZRXYEK-GSWUYBTGSA-M 0.000 claims description 12
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 claims description 7
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 claims description 7
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 7
- 229910052742 iron Inorganic materials 0.000 claims description 7
- 239000011707 mineral Substances 0.000 claims description 7
- 235000010755 mineral Nutrition 0.000 claims description 7
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 claims description 7
- 235000005493 rutin Nutrition 0.000 claims description 7
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 claims description 7
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 claims description 7
- 229960004555 rutoside Drugs 0.000 claims description 7
- 229960001138 acetylsalicylic acid Drugs 0.000 claims description 6
- 239000006071 cream Substances 0.000 claims description 6
- 239000002674 ointment Substances 0.000 claims description 6
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims description 5
- 229960005489 paracetamol Drugs 0.000 claims description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 4
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 3
- 239000011669 selenium Substances 0.000 claims description 3
- 229910052711 selenium Inorganic materials 0.000 claims description 3
- 235000011649 selenium Nutrition 0.000 claims description 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 2
- 229930003427 Vitamin E Natural products 0.000 claims description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 2
- 235000019155 vitamin A Nutrition 0.000 claims description 2
- 239000011719 vitamin A Substances 0.000 claims description 2
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 claims description 2
- 235000005282 vitamin D3 Nutrition 0.000 claims description 2
- 239000011647 vitamin D3 Substances 0.000 claims description 2
- 235000019165 vitamin E Nutrition 0.000 claims description 2
- 229940046009 vitamin E Drugs 0.000 claims description 2
- 239000011709 vitamin E Substances 0.000 claims description 2
- 229940045997 vitamin a Drugs 0.000 claims description 2
- 229940021056 vitamin d3 Drugs 0.000 claims description 2
- 239000011701 zinc Substances 0.000 claims description 2
- 229910052725 zinc Inorganic materials 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims 4
- 229940091258 selenium supplement Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 abstract description 6
- 229940079593 drug Drugs 0.000 abstract description 5
- 230000000202 analgesic effect Effects 0.000 abstract 1
- 230000010534 mechanism of action Effects 0.000 abstract 1
- 239000012873 virucide Substances 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 4
- 150000003722 vitamin derivatives Chemical class 0.000 description 4
- 208000007101 Muscle Cramp Diseases 0.000 description 3
- 239000000812 cholinergic antagonist Substances 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 230000005906 menstruation Effects 0.000 description 3
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 241000701085 Human alphaherpesvirus 3 Species 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 206010039509 Scab Diseases 0.000 description 2
- 241000700584 Simplexvirus Species 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 2
- 230000002921 anti-spasmodic effect Effects 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000008822 capillary blood flow Effects 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 229940014144 folate Drugs 0.000 description 2
- 235000019152 folic acid Nutrition 0.000 description 2
- 239000011724 folic acid Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- -1 nicotinamide, vitamin Chemical class 0.000 description 2
- 235000008160 pyridoxine Nutrition 0.000 description 2
- 239000011677 pyridoxine Substances 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 235000019192 riboflavin Nutrition 0.000 description 2
- 239000002151 riboflavin Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 235000019157 thiamine Nutrition 0.000 description 2
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- 239000011721 thiamine Substances 0.000 description 2
- 229940011671 vitamin b6 Drugs 0.000 description 2
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003537 Vitamin B3 Natural products 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940125681 anticonvulsant agent Drugs 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 230000003821 menstrual periods Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229940115160 morning after Drugs 0.000 description 1
- 210000003739 neck Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- 235000018343 nutrient deficiency Nutrition 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001790 virustatic effect Effects 0.000 description 1
- 235000019160 vitamin B3 Nutrition 0.000 description 1
- 239000011708 vitamin B3 Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A61K31/51—Thiamines, e.g. vitamin B1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
·· ♦· · ·· KATHARINA ORAHTEK·· ♦· · ·· KATHARINA ORAHTEK
Vitaminhaltige Arzneizubereitung 6^ ',', /,",",",V s*,"s "*'" Vitamin-containing medicinal preparation 6 ^ ',', /,",",",V s *," s "*'"
Acetylsalicylsäure plus VitamineAcetylsalicylic acid plus vitamins
Gegenstand der Erfindung ist eine vitaminhaltige Arzneizubereitung (Acetylsalicylsäure plus Vitamine), bei der, der Therapieerfolg verbessert und unerwünschte Nebenwirkungen vermindert sind.The invention relates to a vitamin-containing medicinal preparation (acetylsalicylic acid plus vitamins) in which the therapeutic success is improved and undesirable side effects are reduced.
Eines, der am häufigsten verwendeten Schmerzmittel ist die ASS enthaltene (Brause-) Tablette. Derartige (Brause-) Tabletten enthalten meist 100 (bis 1000 mg) ASS.One of the most commonly used painkillers is the (effervescent) tablet containing ASA. Such (effervescent) tablets usually contain 100 (up to 1000 mg) ASA.
Das Spektrum der therapeutischen Verwendung einer derartigen (Brause-) Tablette, das vom Einsatz zur Erreichung einer Blutverdünnung in therapeutischem Bereich reicht, die durch das Behindern der Thrombozytenaggregation entsteht, und das sich bis hin zur Schmerztherapie erstreckt..The spectrum of therapeutic use of such an (effervescent) tablet ranges from the use to achieve blood thinning in the therapeutic range, which is caused by the inhibition of platelet aggregation, to pain therapy.
Die ASS (Brause-)Tablette wird viel in der Schmerztherapie, bevorzugt zur Therapie von Kopfschmerzen verwendet.The ASA (effervescent) tablet is often used in pain therapy, preferably for the treatment of headaches.
Da die ASS (Brause-)Tabletten zur Standartausstattung fast jeder Hausapotheke gehören, und auch vielseitig und oft verwendet werden, stellte sich deshalb die Aufgabe, die an sich guten therapeutischen Eigenschaften der ASS in der Kombination mit Vitaminen und mineralischen Spurenelementen zu verbessern, um den Therapieerfolg zu steigern und störende Nebenwirkungen der ASS zu minimieren.Since ASA (effervescent) tablets are part of the standard equipment of almost every medicine cabinet and are also used in a variety of ways and frequently, the task arose of improving the inherently good therapeutic properties of ASA in combination with vitamins and mineral trace elements in order to increase the therapeutic success and minimize annoying side effects of ASA.
Es ist bekannt, daß unter der Einwirkung von ASS, Vitamin C vermehrt aus dem Körper ausgeschieden wird, deshalb ist eine optimierte Dosis-Wirkungsbeziehung essentiell.It is known that under the influence of ASA, vitamin C is excreted from the body in increased amounts, therefore an optimized dose-effect relationship is essential.
Eine, auch kurzzeitige, d.h. über einige Tage dauernde Negativbilanz der Vitamin C im Organismus, die entweder durch Mehrbedarf oder unzureichende Bedarfsdeckung bzw. vitaminarme, einseitige Nahrungszusammensetzung , oder auch eine Kombination aus allen drei Varianten zugleich, entsteht, ist unter anderem für kleinere manifeste Einbrüche des Immunsystems verantwortlich.
Ein Beispiel dafür sind Zahnfleischentzündungen, Hautentzündungen (Ackne), Herpesmanifestationen, u. s. w.A negative balance of vitamin C in the organism, even short-term, i.e. lasting for a few days, which arises either through increased requirements or insufficient coverage of requirements or a vitamin-poor, one-sided food composition, or even a combination of all three variants at the same time, is responsible, among other things, for minor manifest breakdowns of the immune system.
An example of this is gingivitis, skin inflammation (acne), herpes manifestations, etc.
Eine, über längeren Zeitraum andauernde, unzureichende Versorgung des Organismus mit Vitamin C ruft irreversible Schäden hervor. Ein Beispiel dafür ist die Rückbildung des Zahnfleisches, und somit Freilegung der Zahnhälse, die eine beliebte Angriffsfläche für Karries bilden.An inadequate supply of vitamin C to the body over a long period of time causes irreversible damage. One example of this is the receding of the gums, which exposes the necks of the teeth, which are a popular target for tooth decay.
-1--1-
Streßsituationen, Umweltbelastungen, Schmerzzustände, fieberhafte Infekte, erhöhter Genussmittel- und ,oder Zigarettenkonsum , Medikamente (vor allem Analgetika, Antibiotika, Antikonvulsiva, Hormone) und extreme psychische Anforderungen erhöhen massiv den Bedarf an Vitamin C, sowie an allen wasserlöslichen Vitaminen. Mit steigernder Anzahl der oben angesprochenen Punkte, die für eine Person zutreffen, steigt die Wahrscheinlichkeit der wachsenden Inappetenz des Betreffenden, und somit die Gefahr für Nährstoffdefizite, falls der erhöhter Bedarf nicht durch Supplementierung gedeckt wird.Stressful situations, environmental pollution, pain, feverish infections, increased consumption of stimulants and/or cigarettes, medication (especially analgesics, antibiotics, anticonvulsants, hormones) and extreme psychological demands massively increase the need for vitamin C, as well as all water-soluble vitamins. As the number of the above-mentioned points that apply to a person increases, the likelihood of the person's increasing loss of appetite increases, and thus the risk of nutrient deficiencies if the increased need is not covered by supplementation.
An dieser Stelle möchte ich nicht versäumen den Rauschtrankkonsumenten zu erwähnen. Aus mehreren Studien geht ganz klar hervor, daß diese Bevölkerungsgruppe, die sich aus Menschen aller Schichten zusammensetzt, einen erniedrigten Vitamin C- Spiegel aufweist.At this point I would like to mention the drug users. Several studies have clearly shown that this population group, which is made up of people from all walks of life, has a reduced vitamin C level.
Die Ursache hierfür liegt wahrscheinlich in erster Linie in einer verminderten Zufuhr über die Nahrung.The reason for this is probably primarily a reduced intake through food.
Bei Alkoholzufuhr steigt der Verlust an allen wasserlöslichen Vitaminen, vor allem aber sind die Vitamine des Vitamin B-Komplexes, d.h. Vitamin Vit.Bi (Thiamin), Vit.Ba (Riboflavin), Vit.B6 ( Pyridoxin), Folat, Nicotinamid, Vit.Bs ( Dexapanthenol) und Vit.B3 (Biotin), des weiteren Vitamin C sowie mehrere mineralische Spurenelemente davon betroffen; aber auch für den Alkoholabbau braucht der Körper zusätzliche Vitamine des Vitamin B-Komplexes und Vitamin C.When alcohol is consumed, the loss of all water-soluble vitamins increases, but above all the vitamins of the vitamin B complex are affected, i.e. vitamin Bi (thiamine), vitamin Ba (riboflavin), vitamin B 6 (pyridoxine), folate, nicotinamide, vitamin Bs (dexapanthenol) and vitamin B3 (biotin), as well as vitamin C and several mineral trace elements; but the body also needs additional vitamins of the vitamin B complex and vitamin C to break down alcohol.
Der Jahresalkoholkonsum in Deutschland beträgt pro Kopf ca. 111 an reinem Alkohol; d.h. im Bundesdurchschnitt werden knapp 7% der Gesamtkalorien in Form von Alkohol konsumiert.Annual alcohol consumption in Germany is approximately 111 liters of pure alcohol per capita, i.e. on average across Germany, almost 7% of total calories are consumed in the form of alcohol.
Bei etwa 35% der Männer und 10% der Frauen im erwerbstätigen Alter ist Alkohol die Ursache für eine Krankenhausbehandlung.Alcohol is the cause of hospital treatment for approximately 35% of men and 10% of women of working age.
Hinzu kommt es noch zusätzlich, daß sehr viele Alkoholkonsumenten auch gleichzeitig mäßige bis starke Raucher sind.In addition, many alcohol consumers are also moderate to heavy smokers.
Studiert man ihren Verhaltensmuster, so fällt eine Sache besonders auf, nämlich, daß sie den, durch Alkoholkonsum bedingten Kopfschmerz „am Morgen danach" faßt ausnahmslos gleich behandeln, und zwar mit starkem Kaffee und der ASS!If you study their behavioral patterns, one thing is particularly striking: they almost always treat the morning-after headache caused by alcohol consumption in the same way: with strong coffee and aspirin!
Durch die ASS werden jedoch inflammatorische Prozesse im Körper begünstigt.However, ASA promotes inflammatory processes in the body.
Das Hinzufügen von Rutosidum zu ASS mit Vitamin C hat sich als ein Wirkungsverstärker des Vitamin C erwiesen. Außerdem fördert das Rutosidum die Kapillardurchblutung, und verhilft so zu schnelleren Schmerzfreiheit.Adding rutin to aspirin with vitamin C has been shown to enhance the effects of vitamin C. In addition, rutin promotes capillary blood flow, thus helping to relieve pain more quickly.
-2--2-
Es wurde weiterhin gefunden, daß die Wirkung der ASS (Brause-)Tablette erheblich gesteigert werden kann, wenn in eine (Brause-)Tablette zusätzlich die Vitamine des Vitamin B-Komplexes, d.h. Vitamin Vit.Bi (Thiamin), Vit.B2 (Riboflavin), Vit.Bo ( Pyridoxin) ,Folat, Nicotinamid, Vit.Bs ( Dexapanthenol) und Vit.B3 (Biotin) hinzugefügt werden.It was also found that the effect of the ASA (effervescent) tablet can be significantly increased if the vitamins of the vitamin B complex, i.e. vitamin Vit.Bi (thiamine), Vit.B2 (riboflavin), Vit.Bo (pyridoxine), folate, nicotinamide, Vit.Bs (dexapanthenol) and Vit.B3 (biotin) are added to an (effervescent) tablet.
Die wasserlöslichen Vitamine des Vitamin B -Komplexes üben eine protektive Schutzwirkung auf den gesamten Magen-Darmbereich aus.
Da die Vitamine des Vitamin B-Komplexes wichtige Bestandteile vieler Synthesewegen und notwendig für ein gesundes Nervensystem sowie eine gesunde Hirnfunktion sind, und ihr Bedarf bei Schmerzzuständen bzw. Fieber d.h. Streß, oder nach Alkoholkonsum zunimmt; so zeigt die Kombination der Vitamine des Vitamin B-Komplexes mit der ASS einen durchschlagenden Erfolg bei der Schmerzbekämpfung sowie Linderung der Erschöpfungszustände, und steigert so die Lebensqualität.The water-soluble vitamins of the vitamin B complex have a protective effect on the entire gastrointestinal tract.
Since the vitamins of the vitamin B complex are important components of many synthesis pathways and are necessary for a healthy nervous system and healthy brain function, and their need increases in cases of pain or fever, i.e. stress, or after alcohol consumption, the combination of the vitamins of the vitamin B complex with ASA shows a resounding success in combating pain and relieving states of exhaustion, and thus improves the quality of life.
Fügt man noch das mineralische Spurenelement Zink hinzu, so kann man stark die inflammatorischen Prozesse im Körper minimieren; auch übermäßige Schweißbildung an Extremitäten konnte erfolgreich vermindert werden.
Wie alle anderen Arzneimittel, so zeigt auch die ASS ein Apex des Wirkungsmaximum. Beim Abnehmen der Wirkung zeigen vor allem die Vitamine des Vitamin B-Komplexes, aber auch Vitamin C eine gewisse Pufferwirkung, die eine Verlängerung der schmerzfreien Zeit bewirken.If you add the mineral trace element zinc, you can greatly minimize the inflammatory processes in the body; excessive sweating on the extremities can also be successfully reduced.
Like all other drugs, ASA also has an apex of maximum effectiveness. When the effectiveness decreases, the vitamins of the vitamin B complex in particular, but also vitamin C, show a certain buffering effect, which leads to an extension of the pain-free period.
Mit dieser Kombination von ASS mit Vitaminen und mineralischen Spurenelementen kann man eine höhere Lebensqualität, sowie eine gewisse Leistungssteigerung erreichen, da in vielen Fällen die wiederholter Gaben der ASS nicht mehr notwendig sind, oder die Zeitintervalle der Einzelgaben stark verzögert werden können, ist es daraus ersichtlich, daß dadurch auch Nebenwirkungen minimiert werden..With this combination of ASA with vitamins and mineral trace elements, one can achieve a higher quality of life, as well as a certain increase in performance, since in many cases repeated doses of ASA are no longer necessary, or the time intervals between individual doses can be greatly delayed, it is clear that this also minimizes side effects.
N-Butylscopolaminiumbromid mit Vit.C, Vit B-Komplex, EisenN-Butylscopolamine bromide with Vit.C, Vit B complex, iron
N-Butylscopolaminiumbromid, ein Spasmolytikum, das bei leichten bis mäßigen Schmerzen im Bereich von Magen und Darm sowie des weiblichen Genitale.N-butylscopolamine bromide, an antispasmodic used for mild to moderate pain in the stomach and intestines as well as the female genitals.
N-Butylscopolaminiumbromid wird viel in der Gynäkologie verwendet, gerade wegen seiner krampflösenden Wirkung, und ist ein Spasmolytikum der ersten Wahl bei menstruallen Beschwerden.N-Butylscopolamine bromide is widely used in gynecology, precisely because of its antispasmodic effect, and is a spasmolytic of choice for menstrual complaints.
Viele Frauen nehmen regelmäßig N-Butylscopolaminiumbromid schon mehrere Tage d.h.5 - 3 Tage vor der monatlichen Menstruation ein, weil da schon die prämenstruallen Beschwerden aufzutreten beginnen.Many women regularly take N-butylscopolamine bromide several days, i.e. 5 - 3 days, before their monthly menstruation, because this is when premenstrual symptoms begin to appear.
-3--3-
Bei vielen Frauen sind jedoch die starken Schmerzen sowie auftretende Spasmen mit einer Anämie verbunden. Es wurde nun gefunden, daß die Zugabe von Eisen in ein N-Butylscopolaminiumbromidpräparat mit Vitaminen, des Vitamin B-Komplexes und Vitamin C eine beachtliche Schmerzfreiheit mit sich brachte.However, in many women the severe pain and spasms that occur are associated with anemia. It has now been found that the addition of iron to an N-butylscopolamine bromide preparation with vitamins, the vitamin B complex and vitamin C resulted in considerable relief from pain.
Auch die Schmerzen sowie die Spasmen, die während der Menstruation auftreten, konnten erfolgreich gesenkt werden; bei insgesamt niedriger Dosierung der eingenommenen N-Butylscopolaminiumbromid-Tabletten in der Kombination mit Vitaminen des Vitamin B-Komplexes , Vitamin C und Eisen. Mit dieser Kombination konnte eine höhere Lebensqualität durch größere Schmerz - und Krampffreiheit erreicht werden, während der prämenstruallen Tage sowie der Menstruation.The pain and spasms that occur during menstruation were also successfully reduced, with a low overall dosage of N-butylscopolamine bromide tablets taken in combination with vitamins from the vitamin B complex, vitamin C and iron. With this combination, a higher quality of life was achieved through greater freedom from pain and cramps during the premenstrual days and menstruation.
N-Butylscopolaminiumbromid mit Paracetamol, Vit.C, Vit.B-Komplex, EisenN-butylscopolamine bromide with paracetamol, Vit.C, Vit.B complex, iron
N-Butylscopolaminiumbromid mit Paracetamol, ein Spasmolytikum, des bei starken Schmerzen verabreicht wird.N-butylscopolamine bromide with paracetamol, an antispasmodic drug used in cases of severe pain.
N-Butylscopolaminiumbromidpräparat mit Paracetamol wird ebenfalls viel in der Gynäkologie verwendet. Dieses Präparat in dieser Kombination wird von Frauen mit sehr starken menstruallen Beschwerden eingenommen, die meistens noch mit größeren Blutverlusten einhergehen.N-butylscopolamine bromide preparation with paracetamol is also widely used in gynecology. This preparation in this combination is taken by women with very severe menstrual problems, which are usually accompanied by major blood loss.
Es wurde nun gefunden, daß gerade eine Kombination in einem Präparat aus N-Butylscopolaminiumbromid und Paracetamol mit Eisen sowie mit Vitaminen des Vitamin B-Komplexes und Vitamin C, das beste Ergebnis brachte. Es konnten sogar die Zeitintervalle bei der Einnahme der Einzelgaben verlängert werden. Die Vitamine des Vitamin B-Komplexes sowie Vitamin C brachten eine Verbesserung des Hautzustandes während der menstruallen Zeit.It was found that a combination of N-butylscopolamine bromide and paracetamol with iron, vitamins from the vitamin B complex and vitamin C produced the best results. The time intervals between taking the individual doses could even be extended. The vitamins from the vitamin B complex and vitamin C improved the condition of the skin during the menstrual period.
Aciclovir mit VitaminenAciclovir with vitamins
Aciclovir, ein Virostatikum, das bei Herpes - Simplex - Viren (Typl und 2) und bei Varizella - Zoster - Virus verabreicht wird. Patienten, die an diese Krankheit erkrankt sind, erleiden sehr oft Rückfälle dieser Erkrankung. Vor allem bei geschädigtem bzw. geschwächtem Immunsystem wird diese Erkrankung manifest.Aciclovir, a virostatic drug that is administered for herpes simplex viruses (types 1 and 2) and varicella zoster viruses. Patients suffering from this disease often suffer relapses of the disease. This disease manifests itself primarily in people with a damaged or weakened immune system.
Um die recht beachtlichen Rückfallquoten der Erkrankung zu minimieren, wurde es nun gefunden, daß man diese durch das Hinzufügen von Vitamin C zum Hauptwirkstoff Aciclovir, und zwar im Verhältnis 2:1 (Aciclovir : Vitamin C), des weiteren Rutosidum ( im Verhältmisl : 4 mit Vitamin C), sowie die, zum B-Komplex gehörenden Vitamine, erfolgreich präventiv behandeln kann.In order to minimize the considerable relapse rates of the disease, it has now been found that it can be successfully treated preventively by adding vitamin C to the main active ingredient aciclovir, in a ratio of 2:1 (aciclovir : vitamin C), as well as rutin (in a ratio of 4 with vitamin C), as well as the vitamins belonging to the B complex.
-4--4-
Durch diese Kombination von Aciclovir mit Vitaminen (Vitamin C. Rutosidum, sowie die, zum B-Komplex gehörenden Vitamine) wurde eine viel effektivere Behandlungsweise entwickelt, da der Krankheitsverlauf mildere Formen zeigt.This combination of acyclovir with vitamins (vitamin C, rutin, and the vitamins belonging to the B complex) has resulted in a much more effective treatment, as the course of the disease is milder.
Da das Rutosidum die Wirksamkeit von Vitamin C steigert und die Kapillardurchblutung fördert, konnte dadurch die an sich gute therapeutische Wirkung von Aciclovir effizienter als bisher entfaltet werden.Since rutin increases the effectiveness of vitamin C and promotes capillary blood flow, the otherwise good therapeutic effect of aciclovir can be developed more efficiently than before.
Auch die typischen Bläschen bzw. Blasen, die im Verlauf der Behandlung Hautdefekte sowie Hautflecken verursachen, konnten durch das gezielte Hinzufügen von Vitaminen, die zu den Vitaminen des Vitamin B-Komplexes gehören, zu dem Hauptwirkstoff Aciclovir verringert werden.The typical blisters or bubbles that cause skin defects and skin spots during the course of treatment could also be reduced by the targeted addition of vitamins that belong to the vitamin B complex to the main active ingredient aciclovir.
Die Behandlung konnte mit viel größerem Erfolg, schneller abgeschlossen werden. Mit dieser neuartigen Kombination von Aciclovir mit Vitaminen konnten auch die Rückfallquoten erheblich minimiert werden.The treatment was completed more quickly and with much greater success. This new combination of aciclovir with vitamins also significantly reduced the relapse rate.
Aciclovir-Salbe (Creme) mit Vitaminen und mineralischem SpurenelementAciclovir ointment (cream) with vitamins and mineral trace elements
Zur äußeren Behandlung von manifesten Krankheitssymptomen der Herpes Simplex - Viren (Typl und 2) und bei Varizella - Zoster - Virus, wird eine Salbe (Creme) mit dem Hauptwirkstoff Aciclovir verwendet.For the external treatment of manifest symptoms of the herpes simplex virus (types 1 and 2) and the varicella zoster virus, an ointment (cream) with the main active ingredient aciclovir is used.
Auch hierbei wurde gefunden, daß die Wirkung der Aciclovir-Salbe (Creme) erheblich gesteigert werden konnte, wenn man zu dem, in der Salbe (Creme) enthaltenen Hauptwirkstoff Aciclovir, die fettlöslichen Vitamine ( Vitamin A, Vitamin E, Vitamin D3), das mineralische Spurenelement Selen, sowie minimale Dosis der, zum Vitamin B-Komplexes gehörenden Vitamine, hinzufügte.Here too, it was found that the effect of the acyclovir ointment (cream) could be significantly increased if the fat-soluble vitamins (vitamin A, vitamin E, vitamin D3), the mineral trace element selenium, and a minimal dose of the vitamins belonging to the vitamin B complex were added to the main active ingredient acyclovir contained in the ointment (cream).
Mit dieser Kombination der radikalbindenden Antioxidanten, wurde der synergische Effekt dieser Vitamine in Verbindung mit Selen ausgenutzt, um mit minimalen Dosen den Heilungsprozeß erfolgreich zu beschleunigen.With this combination of radical-binding antioxidants, the synergistic effect of these vitamins in combination with selenium was exploited to successfully accelerate the healing process with minimal doses.
Durch diese neuartige Kombination von Aciclovir - Salbe (Creme) mit den o. g. Vitaminen konnte das Einreißen des, bei dem Blasenabheilungsprozeß entstandenen Schorfs verhindert werden.This novel combination of aciclovir ointment (cream) with the above-mentioned vitamins prevented the scabs that had formed during the blister healing process from tearing.
Die entstandenen Hautdefekte sowie die Hautflecken konnten nun schneller und erfolgreicher behandelt werden. Auch der Juckreiz des abheilenden Schorfs konnte beachtlich minimiert werden.The resulting skin defects and skin spots could now be treated more quickly and successfully. The itching of the healing scabs could also be significantly minimized.
-5--5-
Claims (6)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE20305898U DE20305898U1 (en) | 2003-04-03 | 2003-04-03 | Pharmaceutical compositions include vitamins and optionally trace elements to enhance the therapeutic effect and/or reduce the side effects of drugs |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE20305898U DE20305898U1 (en) | 2003-04-03 | 2003-04-03 | Pharmaceutical compositions include vitamins and optionally trace elements to enhance the therapeutic effect and/or reduce the side effects of drugs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE20305898U1 true DE20305898U1 (en) | 2003-07-31 |
Family
ID=27675371
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE20305898U Expired - Lifetime DE20305898U1 (en) | 2003-04-03 | 2003-04-03 | Pharmaceutical compositions include vitamins and optionally trace elements to enhance the therapeutic effect and/or reduce the side effects of drugs |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE20305898U1 (en) |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4702918A (en) | 1984-08-03 | 1987-10-27 | Nippon Shinyaku Co. Ltd. | Pharmaceutical preparations and a method of manufacturing them |
| DE19502789A1 (en) | 1995-01-28 | 1996-08-01 | Dirk Krischenowski | Medicament contg. analgesic, antacid, and/or vitamin etc. |
| DE19633446A1 (en) | 1996-08-20 | 1998-02-26 | Abolghassem Prof Dr M Pakdaman | A composition comprises several lipid lowering plant extracts |
| US5837285A (en) | 1992-02-18 | 1998-11-17 | Nakamichi; Kouichi | Fast soluble tablet |
| US6180662B1 (en) | 1994-12-13 | 2001-01-30 | Beiersdorf Ag | Agents acting against hyperreactive and hypoactive, deficient skin conditions and manifest dermatitides |
| DE10045022A1 (en) | 2000-09-12 | 2002-04-25 | Adelholzener Alpenquellen Gmbh | Medical drink with health benefits |
| US20020114833A1 (en) | 2000-12-06 | 2002-08-22 | Abu-Izza Khawla A. | Fast dissolving tablet |
| DE10204634A1 (en) | 2001-02-05 | 2002-10-31 | Greither Salus Haus Dr Otto | Composition useful as a food or food supplement, and for treating e.g. tumors or osteoporosis, contains isoflavone, lignan and phytosterol |
| DE10158046A1 (en) | 2001-11-27 | 2003-06-05 | Basf Ag | Formulation for use in food, food supplements, animal feed, feed additives, pharmaceutical and cosmetic preparations and processes for their preparation |
-
2003
- 2003-04-03 DE DE20305898U patent/DE20305898U1/en not_active Expired - Lifetime
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4702918A (en) | 1984-08-03 | 1987-10-27 | Nippon Shinyaku Co. Ltd. | Pharmaceutical preparations and a method of manufacturing them |
| US5837285A (en) | 1992-02-18 | 1998-11-17 | Nakamichi; Kouichi | Fast soluble tablet |
| US6180662B1 (en) | 1994-12-13 | 2001-01-30 | Beiersdorf Ag | Agents acting against hyperreactive and hypoactive, deficient skin conditions and manifest dermatitides |
| DE19502789A1 (en) | 1995-01-28 | 1996-08-01 | Dirk Krischenowski | Medicament contg. analgesic, antacid, and/or vitamin etc. |
| DE19633446A1 (en) | 1996-08-20 | 1998-02-26 | Abolghassem Prof Dr M Pakdaman | A composition comprises several lipid lowering plant extracts |
| DE10045022A1 (en) | 2000-09-12 | 2002-04-25 | Adelholzener Alpenquellen Gmbh | Medical drink with health benefits |
| US20020114833A1 (en) | 2000-12-06 | 2002-08-22 | Abu-Izza Khawla A. | Fast dissolving tablet |
| DE10204634A1 (en) | 2001-02-05 | 2002-10-31 | Greither Salus Haus Dr Otto | Composition useful as a food or food supplement, and for treating e.g. tumors or osteoporosis, contains isoflavone, lignan and phytosterol |
| DE10158046A1 (en) | 2001-11-27 | 2003-06-05 | Basf Ag | Formulation for use in food, food supplements, animal feed, feed additives, pharmaceutical and cosmetic preparations and processes for their preparation |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10369182B2 (en) | Compositions and methods for treating insomnia and other sleep related disorders | |
| DE3639038C2 (en) | Use of S - (+) - ibuprofen for rapid treatment of human pain | |
| WO1984001899A1 (en) | New utilization of a unique vitamin or a combination of various vitamins | |
| WO2014031964A1 (en) | Composition for the treatment of migraine headaches | |
| JP2002518456A (en) | Dietary supplements to support normal cerebrovascular conditions | |
| DE19818563C2 (en) | Use of alpha lipoic acid to reduce appetite and / or to reduce body weight | |
| US5612061A (en) | Composition and method for the treatment of premenstrual syndrome | |
| EP0037488A2 (en) | Pharmaceutical composition for healing inflammatory and/or degenerative and/or atrophic mucous membranes | |
| JP2024061731A (en) | Dietary supplement for use in the prevention and treatment of migraine | |
| JPH04243825A (en) | Remedy for pigmentation | |
| DE3500670C2 (en) | ||
| DE2350721C2 (en) | Ophthalmic agent for oral administration | |
| EP1513533A2 (en) | Pharmaceutical active substance combination and the use thereof | |
| EP1001756B1 (en) | Synergistically acting compositions for selectively combating tumor tissue | |
| EP1784177B1 (en) | Formulation for l-tryptophane comprising carbidopa/benserazide | |
| DE69424679T2 (en) | COMPOSITION FOR TREATING OR PREVENTING HERPES | |
| DE20305898U1 (en) | Pharmaceutical compositions include vitamins and optionally trace elements to enhance the therapeutic effect and/or reduce the side effects of drugs | |
| EP1673080A2 (en) | Pharmaceutical combination preparation containing glycyrrhizine, zinc, and a compound comprising a thiol group or a group that is metabolized thereto | |
| EP0018550B1 (en) | Compositions for muscular disease treatment | |
| DE69018022T2 (en) | Magnesium citrate as a dietary supplement. | |
| DE2820900A1 (en) | MEDICINAL PRODUCTS FOR THE TREATMENT OF GASTRITIDES, GASTRODUODENITIDES AND GASTRODUODENAL ULCERA | |
| DE3247514C2 (en) | ||
| US20240226046A1 (en) | Composition containing lysine for the treatment of poison ivy, composition containing lysine for the prevention of poison ivy, processes, and method of use | |
| EP0358683A1 (en) | Pharmaceutical substance | |
| DE10053155A1 (en) | Treatment of psoriasis comprises administration of a multivitamin preparation containing vitamins B1, B2, B6, B12, C and E, nicotinamide, dexpanthenol, biotin and folic acid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R086 | Non-binding declaration of licensing interest | ||
| R207 | Utility model specification |
Effective date: 20030904 |
|
| R163 | Identified publications notified |
Effective date: 20030730 |
|
| R156 | Lapse of ip right after 3 years |
Effective date: 20061101 |